(CIDRAP News) In view of the specter of bioterrorism, it's time to overhaul the hodgepodge of outdated, little-known, inconsistent state laws dealing with public health emergencies in the United States, an expert on the subject told a conference audience in Minneapolis yesterday.
(CIDRAP News) The United States' food supply makes an attractive target for terrorists, and people in the food industry need to talk more frankly about the risks, bioterrorism expert Michael T. Osterholm, PhD, MPH, said in a Minneapolis speech yesterday.
(CIDRAP News) Now that the federal government has some licensed smallpox vaccine in its stockpile, a presidential announcement on vaccination recommendations may be coming very soon, bioterrorism expert Michael T. Osterholm, PhD, MPH, predicted last week.
"I believe that in the next days you'll be hearing from the president about this vaccine," Osterholm told healthcare workers at a meeting in Minneapolis.
(CIDRAP News) Federal health officials project that about half of the estimated 10 million health and emergency response workers targeted for the second round of smallpox vaccinations will refuse the shots.
(CIDRAP News) The debut of irradiated ground beef in school cafeterias grew more likely yesterday with the US Department of Agriculture's (USDA's) announcement that it will make the product available to schools starting next January.
(CIDRAP News) The University of Minnesota and Texas A&M University will receive a total of $33 million to set up centers to research food contamination threats and foreign animal diseases, the Department of Homeland Security (DHS) announced today.
(CIDRAP News) The vaccine supply for the soon-to-begin influenza season is suddenly in serious condition with news that Chiron Corp., maker of about half the US supply, has been ordered to stop production by British health authorities and will not be shipping its doses.
(CIDRAP News) A refrigerated form of MedImmunes FluMist intranasal influenza vaccine has been shown to be as effective as the standard frozen form in stimulating the immune system, the company says.
(CIDRAP News) – A recent report about the use of blood products to treat patients in the Spanish influenza pandemic of 1918 has sparked interest among those concerned about the threat of the next pandemic, but experts say it's far from clear whether the approach would be practicable in a pandemic today.